December 26, 2021
Article
Although combination carbidopa-levodopa has become a standard for the treatment of many of the motor features of PD to this day, gait dysfunction remains a difficult symptom to treat.
FDA Accepts New Drug Application for Intranasal Zavegepant to Treat Acute Migraine
Tackling Neurodegeneration in Multiple Sclerosis: Emily Harrington, MD, PhD
Periconceptional Folic Acid Supplementation Decreases Risk of Preterm Birth in Epilepsy
Changing the Future of Stroke Care: The 2021 ASA/AHA Prevention Guidelines